We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Procaps Group SA (PROC) USD0.01

Sell:$2.25 Buy:$2.40 Change: $0.01 (0.43%)
Market closed |  Prices as at close on 2 January 2025 | Switch to live prices |
Sell:$2.25
Buy:$2.40
Change: $0.01 (0.43%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 2 January 2025 | Switch to live prices |
Sell:$2.25
Buy:$2.40
Change: $0.01 (0.43%)
Market closed |  Prices as at close on 2 January 2025 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Procaps Group SA is a Luxembourg-based healthcare and pharmaceutical company. The Company develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. It operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs.

Contact details

Address:
9, rue de Bitbourg
LUXEMBOURG
1273
Luxembourg
Telephone:
+ ()
Website:
https://www.procapsgroup.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PROC
ISIN:
LU2376511205
Market cap:
$264.01 million
Shares in issue:
112.82 million
Sector:
Pharmaceuticals
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Alejandro Kostia Weinstein Crenovich
    Executive Chairman of the Board
  • Camilo Camacho
    President
  • Jose Vieira
    Chief Executive Officer
  • Melissa Angelini
    Interim Vice President - Finance
  • Mauricio Castaneda Caballero
    Vice President - Human Resources
  • Marcela Carvajalino Pagano
    Vice President - Corporate and Legal Affairs
  • Grethel Moreno Romero
    Vice President - Audit and Internal Controls
  • Luis Alberto Palacios Aragon
    Vice President - International Marketing and R&D
  • Patricio Vargas Munoz
    Chief Optimization and Rationalization Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.